Healthcare Services

Losartan Market Forecast Assessing Growth Potential And Industry Direction

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Expansion Is Expected For The Losartan Market Over The Forecast Period?

The losartan market has experienced steady expansion in recent years. Its value is projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, at a compound annual growth rate (CAGR) of 4.2%. Historically, this development can be linked to factors such as the escalating global burden of hypertension, the widespread clinical acceptance of ARBs, the increasing incidence of diabetes-related kidney disease, enhanced awareness of cardiovascular risk management, and an early transition from ACE inhibitors to ARBs.

The market size for losartan is anticipated to show consistent expansion over the upcoming years. Its valuation is projected to reach $1.83 billion by 2030, achieving a compound annual growth rate (CAGR) of 4.3%. The projected growth within this period stems from drivers such as an expanding aging demographic, an increasing requirement for kidney-protective antihypertensive medications, broader availability of inexpensive generic versions, a heightened emphasis on stroke prevention, and greater healthcare expenditure dedicated to managing chronic diseases. Significant trends expected during the forecast timeframe include the rising occurrence of hypertension and cardiovascular conditions, a developing inclination towards ARBs rather than ACE inhibitors, a wider distribution of generic losartan prescriptions, its growing application in the management of diabetic nephropathy, and an increase in the adoption of long-term blood pressure control therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Significant Factors Are Encouraging Growth In The Losartan Market?

The increasing occurrence of hypertension is anticipated to propel the expansion of the losartan market in the future. Hypertension, characterized by consistently elevated blood pressure, significantly increases the risk of heart disease, stroke, and various other serious health issues. This rising incidence of hypertension is often linked to diets high in salt and processed items, contributing to fluid retention and putting extra stress on the heart. Losartan aids in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action promotes relaxation and widening of the vessels, thereby reducing blood pressure and alleviating the heart’s effort. For example, in January 2025, according to the Centers for Disease Control and Prevention, a US-based organisation, in 2023, high blood pressure played a primary or contributing role in 664,470 deaths in the United States. Consequently, the expanding prevalence of hypertension is a key factor driving the growth of the losartan market.

What Segment Categories Are Evaluated In The Losartan Market Study?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Trends Are Influencing The Losartan Market Outlook?

Major companies operating in the losartan market are emphasizing the development of innovative products and securing approvals, such as losartan potassium oral suspension, to enhance patient compliance and broaden therapeutic applications. Losartan potassium oral suspension is a liquid form of the medication losartan potassium, intended for individuals who experience difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. This is a ready-to-use liquid formulation designed for hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. It provides precise dosing without compounding and is supplied as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Key Market Participants In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Region Has The Strongest Presence In The Losartan Market?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Losartan Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795